Aristides Capital LLC Buys 1,197 Shares of Maximus, Inc. (NYSE:MMS)

Aristides Capital LLC lifted its stake in shares of Maximus, Inc. (NYSE:MMS) by 48.5% during the 4th quarter, HoldingsChannel.com reports. The firm owned 3,667 shares of the health services provider’s stock after buying an additional 1,197 shares during the period. Aristides Capital LLC’s holdings in Maximus were worth $274,000 at the end of the most recent reporting period.

Other hedge funds also recently modified their holdings of the company. UMB Bank n.a. grew its stake in Maximus by 79.8% during the fourth quarter. UMB Bank n.a. now owns 356 shares of the health services provider’s stock worth $27,000 after buying an additional 158 shares in the last quarter. Eastern Bank bought a new stake in shares of Maximus during the 4th quarter worth approximately $29,000. V Square Quantitative Management LLC boosted its position in shares of Maximus by 65.9% during the 4th quarter. V Square Quantitative Management LLC now owns 453 shares of the health services provider’s stock worth $34,000 after acquiring an additional 180 shares in the last quarter. R Squared Ltd bought a new position in Maximus in the fourth quarter valued at approximately $54,000. Finally, IFP Advisors Inc raised its position in Maximus by 62.4% during the fourth quarter. IFP Advisors Inc now owns 786 shares of the health services provider’s stock valued at $59,000 after purchasing an additional 302 shares in the last quarter. Institutional investors own 97.21% of the company’s stock.

Analysts Set New Price Targets

A number of equities research analysts have weighed in on the company. StockNews.com downgraded Maximus from a “buy” rating to a “hold” rating in a report on Friday, February 14th. Raymond James raised Maximus from a “market perform” rating to an “outperform” rating and set a $90.00 price objective on the stock in a research note on Thursday, January 2nd.

Insider Buying and Selling at Maximus

In other news, insider Ilene R. Baylinson sold 14,500 shares of the company’s stock in a transaction that occurred on Wednesday, February 19th. The stock was sold at an average price of $68.14, for a total value of $988,030.00. Following the completion of the transaction, the insider now owns 2,512 shares of the company’s stock, valued at $171,167.68. This represents a 85.23 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink. Also, Director Jan Madsen sold 2,439 shares of the firm’s stock in a transaction that occurred on Tuesday, March 18th. The shares were sold at an average price of $67.71, for a total transaction of $165,144.69. Following the completion of the transaction, the director now owns 18,097 shares of the company’s stock, valued at approximately $1,225,347.87. This trade represents a 11.88 % decrease in their position. The disclosure for this sale can be found here. Corporate insiders own 1.60% of the company’s stock.

Maximus Price Performance

MMS stock opened at $68.61 on Monday. The stock has a market cap of $3.88 billion, a price-to-earnings ratio of 14.76 and a beta of 0.68. The company has a debt-to-equity ratio of 0.82, a current ratio of 1.72 and a quick ratio of 1.72. The company has a 50 day simple moving average of $69.16 and a 200 day simple moving average of $77.12. Maximus, Inc. has a 1 year low of $63.77 and a 1 year high of $93.97.

Maximus (NYSE:MMS) last announced its quarterly earnings results on Thursday, February 6th. The health services provider reported $1.61 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.39 by $0.22. Maximus had a net margin of 5.28% and a return on equity of 21.95%. Research analysts anticipate that Maximus, Inc. will post 6.15 EPS for the current fiscal year.

About Maximus

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.